To ask the Scottish Government what support services are available for families affected by exposure to the pregnancy medication, stilbestrol (DES), including fertility, cancer screening and psychological support. The Royal College of Obstetrics and Gynaecology, the professional body for Obstetricians and Gynaecologists in the UK, has recommended that women who believe they may have been exposed to stilbestrol (DES) in utero and who are concerned about the risks of vaginal and cervical cancer should be offered careful monitoring by annual colposcopic examinations in specialist centres.Cervical screening is offered to women who live in Scotland and are aged between 25 and 64 years and we encourage all women to take up routine cervical screening appointments when invited.Evidence for an increased risk of other cancers is less conclusive but participation in the National Breast Screening Programme is recommended.